BMC Microbiol. 2013 May 17;13:110. doi: 10.1186/1471-2180-13-110.
Leucine aminopeptidase (LAP) has been known to be a housekeeping protease, DNA-binding protein and repressor or activator in the operon regulation of virulence-associated genes in several bacterial species. LAP activity was consistently detected in overnight cultures of Burkholderia pseudomallei, the causative agent of melioidosis and this enzyme was partially purified and characterised in this study. The intra- and inter-species nucleotide and deduced amino acid sequence variation of LAP encoding gene (pepA) was determined. A pepA/PCR-RFLP assay was designed to facilitate the identification of major LAP sequence types amongst clinical and environmental isolates of B. pseudomallei.
LAP activity was detected in B. pseudomallei culture supernantants by zymographic analysis. Optimum activity was at pH 9 and stable at 50[degree sign]C. Enhanced enzymatic activity was observed in the presence of metallic ions Mg2+, Ca2+, Na+ and K+. LAP activity was inhibited by EDTA, 1,10-phenanthroline, amastatin, Mn2+ and Zn2+. Sequence analysis of the complete nucleotide and deduced amino acid sequences of LAP-encoding (pepA) gene showed close genetic relatedness to B. mallei (similarity 99.7%/99.6%), but not with B. thailandensis (96.4%/96.4%). Eight pepA sequence types were identified by comparison with a 596 bp DNA fragment encompassing central regions of the pepA gene. A pepA/PCR-RFLP was designed to differentiate pepA sequence types. Based on restriction analysis with StuI and HincII enzymes of the amplified pepA gene, clinical and environmental isolates showed different predominant RFLP types. Type I was the most predominant type amongst 71.4% (65/91) of the clinical isolates, while Type II was predominant in 55.6% (5/9) of the environmental isolates.
This study showed that LAP is a secretory product of B. pseudomallei with features similar to LAP of other organisms. Identification of major LAP sequence types of B. pseudomallei was made possible based on RFLP analysis of the pepA gene. The high LAP activity detected in both B. pseudomallei and B. thailandensis, suggests that LAP is probably a housekeeping enzyme rather than a virulence determinant.
亮氨酸氨肽酶(LAP)已被证明是一种管家蛋白酶、DNA 结合蛋白和操纵子调节中的抑制剂或激活剂,在几种细菌的毒力相关基因的操纵子调节中起作用。在类鼻疽伯克霍尔德菌(导致类鼻疽病的病原体)的过夜培养物中始终检测到 LAP 活性,本研究对该酶进行了部分纯化和表征。测定了 LAP 编码基因(pepA)的种内和种间核苷酸和推导的氨基酸序列变异。设计了 pepA/PCR-RFLP 检测方法,以方便鉴定类鼻疽伯克霍尔德菌临床和环境分离株中的主要 LAP 序列类型。
通过同工酶分析检测到 B. pseudomallei 培养上清液中的 LAP 活性。最佳活性在 pH9 时,在 50°C 时稳定。在存在金属离子 Mg2+、Ca2+、Na+和 K+时,酶活性增强。EDTA、1,10-菲咯啉、抑酶肽、Mn2+和 Zn2+可抑制 LAP 活性。LAP 编码(pepA)基因的完整核苷酸和推导的氨基酸序列的序列分析显示与 B. mallei 密切的遗传关系(相似性 99.7%/99.6%),但与 B. thailandensis 没有关系(96.4%/96.4%)。通过与包含 pepA 基因中心区域的 596 bp DNA 片段比较,确定了 8 种 pepA 序列类型。设计了 pepA/PCR-RFLP 来区分 pepA 序列类型。根据扩增的 pepA 基因用 StuI 和 HincII 酶进行的限制性分析,临床和环境分离株显示出不同的主要 RFLP 类型。I 型是 71.4%(65/91)临床分离株中最主要的类型,而 II 型是 55.6%(5/9)环境分离株中的主要类型。
本研究表明,LAP 是类鼻疽伯克霍尔德菌的一种分泌产物,具有与其他生物体的 LAP 相似的特征。基于 pepA 基因的 RFLP 分析,鉴定了类鼻疽伯克霍尔德菌的主要 LAP 序列类型。在类鼻疽伯克霍尔德菌和 B. thailandensis 中均检测到高 LAP 活性,表明 LAP 可能是一种管家酶,而不是毒力决定因素。